{"name":"Burrill & Company","permalink":"burrill-co","crunchbase_url":"http://www.crunchbase.com/financial-organization/burrill-co","homepage_url":"http://venture.burrillandco.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"(415) 591-5400 ","description":"Life Sciences VC","email_address":"burrill@b-c.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri Apr 10 16:36:07 UTC 2009","updated_at":"Mon Aug 03 22:06:31 UTC 2009","overview":"<p>Burrill &amp; Company invests in life science companies whose technologies and products are applicable across a wide range of life science sub-sectors: human healthcare therapeutics and diagnostics/devices; health/wellness; agricultural biotechnology; biofuels, and industrial biotechnology (biomaterials/bioprocesses).</p>","image":{"available_sizes":[[[150,25],"assets/images/resized/0005/0402/50402v1-max-150x150.png"],[[250,43],"assets/images/resized/0005/0402/50402v1-max-250x250.png"],[[250,43],"assets/images/resized/0005/0402/50402v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"Headquarters","address1":"One Embarcadero Center ","address2":"Suite 2700","zip_code":"94111","city":"San Francisco","state_code":"CA","country_code":"USA","latitude":37.794891,"longitude":-122.397901}],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"G.","last_name":"Steven Burrill","permalink":"g-steven-burrill","image":null}},{"is_past":false,"title":"Managing Director","person":{"first_name":"Dr.","last_name":"Dirk Lammerts","permalink":"dr-dirk-lammerts","image":null}},{"is_past":false,"title":"Managing Director","person":{"first_name":"Dr.","last_name":"Michael Keyoung","permalink":"dr-michael-keyoung","image":null}}],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://venturebeat.com/2009/04/08/aerovance-inhales-38m-for-asthma-drugs/","source_description":"Aerovance inhales $38M for asthma drugs","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":7,"company":{"name":"Aerovance","permalink":"aerovance","image":{"available_sizes":[[[150,75],"assets/images/resized/0004/0827/40827v1-max-150x150.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-250x250.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://earth2tech.com/2009/06/01/khosla-invests-still-more-in-biofuels-hcl-cleantech/","source_description":"Khosla Invests Still More In Biofuels: HCL CleanTech","raised_amount":5500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":1,"company":{"name":"Virdia","permalink":"virdia","image":{"available_sizes":[[[150,60],"assets/images/resized/0004/9212/49212v2-max-150x150.png"],[[155,63],"assets/images/resized/0004/9212/49212v2-max-250x250.png"],[[155,63],"assets/images/resized/0004/9212/49212v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.ospreypharma.com/#investment","source_description":"Osprey Pharmaceuticals","raised_amount":11000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":1,"company":{"name":"Osprey Pharmaceuticals USA","permalink":"osprey-pharmaceuticals-usa","image":{"available_sizes":[[[150,16],"assets/images/resized/0004/9529/49529v1-max-150x150.jpg"],[[250,27],"assets/images/resized/0004/9529/49529v1-max-250x250.jpg"],[[450,50],"assets/images/resized/0004/9529/49529v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2007/03/28/aerovance-asthma-treatment-company-finishes-raising-60m/","source_description":"Aerovance, asthma treatment company, finishes raising $60M","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":28,"company":{"name":"Aerovance","permalink":"aerovance","image":{"available_sizes":[[[150,75],"assets/images/resized/0004/0827/40827v1-max-150x150.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-250x250.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/press-releases/catalyst-biosciences-raises-40-million-series-c-financing?utm_medium=nl&utm_source=internal&cmp-id=EMC-NL-FB&dest=FB","source_description":"Catalyst Biosciences Raises $40 Million in Series C Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":3,"company":{"name":"Catalyst Biosciences","permalink":"catalyst-biosciences","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/0378/50378v1-max-150x150.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-250x250.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2008/05/13/gevo-raises-another-17m-for-synthetic-biofuels/","source_description":"Gevo raises another $17M for synthetic biofuels","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":13,"company":{"name":"Gevo","permalink":"gevo","image":{"available_sizes":[[[150,41],"assets/images/resized/0005/1223/51223v2-max-150x150.png"],[[250,69],"assets/images/resized/0005/1223/51223v2-max-250x250.png"],[[277,77],"assets/images/resized/0005/1223/51223v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://sanjose.bizjournals.com/sanjose/stories/2009/08/03/daily46.html","source_description":"XDx raises $14.4M new funding","raised_amount":14400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":5,"company":{"name":"XDx","permalink":"xdx","image":{"available_sizes":[[[150,68],"assets/images/resized/0005/1083/51083v1-max-150x150.png"],[[220,100],"assets/images/resized/0005/1083/51083v1-max-250x250.png"],[[220,100],"assets/images/resized/0005/1083/51083v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://onbiovc.com/xdx-inc-series-g-144m/","source_description":"XDx, Inc.: Series G $14.4M","raised_amount":14400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":7,"company":{"name":"XDx","permalink":"xdx","image":{"available_sizes":[[[150,68],"assets/images/resized/0005/1083/51083v1-max-150x150.png"],[[220,100],"assets/images/resized/0005/1083/51083v1-max-250x250.png"],[[220,100],"assets/images/resized/0005/1083/51083v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/primeradx-inc-series-c-20m/","source_description":"PrimeraDx, Inc.: Series C $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":30,"company":{"name":"PrimeraDx","permalink":"primeradx","image":{"available_sizes":[[[150,40],"assets/images/resized/0006/4292/64292v3-max-150x150.png"],[[250,66],"assets/images/resized/0006/4292/64292v3-max-250x250.png"],[[450,120],"assets/images/resized/0006/4292/64292v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://venturebeatprofiles.com/company/profile/nanovasc","source_description":"NanoVasc Funding","raised_amount":4700000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":31,"company":{"name":"NanoVasc","permalink":"nanovasc","image":{"available_sizes":[[[150,35],"assets/images/resized/0007/0276/70276v1-max-150x150.jpg"],[[231,55],"assets/images/resized/0007/0276/70276v1-max-250x250.jpg"],[[231,55],"assets/images/resized/0007/0276/70276v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/endocyte-inc-series-c-26m/","source_description":"Endocyte, Inc.: Series C $26M","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":19,"company":{"name":"Endocyte","permalink":"endocyte","image":{"available_sizes":[[[150,74],"assets/images/resized/0007/4250/74250v1-max-150x150.png"],[[193,96],"assets/images/resized/0007/4250/74250v1-max-250x250.png"],[[193,96],"assets/images/resized/0007/4250/74250v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.scalevp.com/news/portfolio/20070112-diadexus.html","source_description":"DiaDexus Raises $40M Series E For Expansion","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":12,"company":{"name":"diaDexus","permalink":"diadexus","image":{"available_sizes":[[[137,69],"assets/images/resized/0004/9821/49821v1-max-150x150.jpg"],[[137,69],"assets/images/resized/0004/9821/49821v1-max-250x250.jpg"],[[137,69],"assets/images/resized/0004/9821/49821v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2007/07/11/ipo-still-on-hold-light-sciences-beams-up-30m/","source_description":"Light Sciences beams up $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":7,"funded_day":11,"company":{"name":"Light Sciences Oncology","permalink":"light-sciences-oncology","image":{"available_sizes":[[[150,39],"assets/images/resized/0006/5310/65310v1-max-150x150.png"],[[244,65],"assets/images/resized/0006/5310/65310v1-max-250x250.png"],[[244,65],"assets/images/resized/0006/5310/65310v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://xdx.com/pdf/XDx-Private-Equity-Financing_1-5-06.pdf","source_description":"XDx Completes $26.5 Million Private Equity Financing","raised_amount":26500000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":5,"company":{"name":"XDx","permalink":"xdx","image":{"available_sizes":[[[150,68],"assets/images/resized/0005/1083/51083v1-max-150x150.png"],[[220,100],"assets/images/resized/0005/1083/51083v1-max-250x250.png"],[[220,100],"assets/images/resized/0005/1083/51083v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.neurotechusa.com/news_events/pr_2006-11-16.asp","source_description":"Neurotechâ„¢, Inc. Completes $35 Million Private Equity Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":16,"company":{"name":"Neurotech","permalink":"neurotech","image":{"available_sizes":[[[150,47],"assets/images/resized/0008/4292/84292v1-max-150x150.jpg"],[[225,71],"assets/images/resized/0008/4292/84292v1-max-250x250.jpg"],[[225,71],"assets/images/resized/0008/4292/84292v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.catalystbiosciences.com/news-pr-seriesb.html","source_description":"CATALYST BIOSCIENCES RAISES $30 MILLION SERIES B FINANCING TO ADVANCE THERAPEUTIC PROTEASES","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":2,"funded_day":9,"company":{"name":"Catalyst Biosciences","permalink":"catalyst-biosciences","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/0378/50378v1-max-150x150.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-250x250.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"","source_description":"Cap Funding Report","raised_amount":9900000,"raised_currency_code":"USD","funded_year":2006,"funded_month":4,"funded_day":3,"company":{"name":"Sciona","permalink":"sciona","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://dc.citybizlist.com/lstg/lstgDetail.aspx?id=4640","source_description":"Adlyfe Inc. Kicks Off 2006 With a $3.3M Series A Round","raised_amount":3300000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":17,"company":{"name":"Adlyfe","permalink":"adlyfe","image":{"available_sizes":[[[150,81],"assets/images/resized/0008/5170/85170v1-max-150x150.jpg"],[[209,113],"assets/images/resized/0008/5170/85170v1-max-250x250.jpg"],[[209,113],"assets/images/resized/0008/5170/85170v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":1600000,"raised_currency_code":"USD","funded_year":2006,"funded_month":4,"funded_day":1,"company":{"name":"Chromatin","permalink":"chromatin","image":{"available_sizes":[[[150,34],"assets/images/resized/0008/5331/85331v1-max-150x150.jpg"],[[247,56],"assets/images/resized/0008/5331/85331v1-max-250x250.jpg"],[[247,56],"assets/images/resized/0008/5331/85331v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss","source_description":"FerroKin rounds up $12M for iron overload treatment  Read more: FerroKin rounds up $12M for iron overload treatment - FierceBiotech http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss#ixz","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":18,"company":{"name":"FerroKin Biosciences","permalink":"ferrokin-biosciences","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.bizjournals.com/stlouis/stories/2005/08/15/focus5.html","source_description":"Chlorogen closing in on $6 million funding round","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":12,"company":{"name":"Chlorogen","permalink":"chlorogen","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/09/newbridge-pharmaceuticals-raises-12m-in.html","source_description":"NewBridge Pharmaceuticals Raises $12M in Series B Financing","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":20,"company":{"name":"NewBridge Pharmaceuticals","permalink":"newbridge-pharmaceuticals","image":{"available_sizes":[[[150,84],"assets/images/resized/0010/2451/102451v1-max-150x150.jpg"],[[150,84],"assets/images/resized/0010/2451/102451v1-max-250x250.jpg"],[[150,84],"assets/images/resized/0010/2451/102451v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2011/08/yaupon-therapeutics-raises-14-4m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Yaupon Therapeutics Raises $14.4M in Series D Funding","raised_amount":14400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":11,"company":{"name":"Yaupon Therapeutics","permalink":"yaupon-therapeutics","image":{"available_sizes":[[[150,66],"assets/images/resized/0014/9091/149091v1-max-150x150.png"],[[210,93],"assets/images/resized/0014/9091/149091v1-max-250x250.png"],[[210,93],"assets/images/resized/0014/9091/149091v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://techcrunch.com/2011/08/23/alivecor-turns-mobile-devices-into-low-cost-heart-monitors-raises-3-million/","source_description":"AliveCor Turns Mobile Devices Into Low-Cost Heart Monitors, Raises $3 Million","raised_amount":3000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":2,"company":{"name":"AliveCor","permalink":"alivecor","image":{"available_sizes":[[[150,35],"assets/images/resized/0014/9115/149115v1-max-150x150.png"],[[250,59],"assets/images/resized/0014/9115/149115v1-max-250x250.png"],[[275,65],"assets/images/resized/0014/9115/149115v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.virdia.com/images/press/virdia_for%20wire_%20march%206.pdf","source_description":"Officially Announces the Closing of $30 Million in Private Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":6,"company":{"name":"Virdia","permalink":"virdia","image":{"available_sizes":[[[150,60],"assets/images/resized/0004/9212/49212v2-max-150x150.png"],[[155,63],"assets/images/resized/0004/9212/49212v2-max-250x250.png"],[[155,63],"assets/images/resized/0004/9212/49212v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.whiteglove.com/about-us/press-releases/764-whiteglove-secures-funding.html","source_description":"WhiteGlove Health Closes Funding Round","raised_amount":12900000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":12,"company":{"name":"WhiteGlove Health","permalink":"whiteglove-house-call-health-2","image":{"available_sizes":[[[150,45],"assets/images/resized/0018/4018/184018v1-max-150x150.png"],[[250,75],"assets/images/resized/0018/4018/184018v1-max-250x250.png"],[[300,91],"assets/images/resized/0018/4018/184018v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/06/ceptaris-therapeutics-raises-10m-series-d-1-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Ceptaris Therapeutics Raises $10M in Series D-1 Funding","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":5,"company":{"name":"Ceptaris Therapeutics","permalink":"ceptaris-therapeutics","image":{"available_sizes":[[[150,42],"assets/images/resized/0017/5338/175338v1-max-150x150.png"],[[250,70],"assets/images/resized/0017/5338/175338v1-max-250x250.png"],[[356,100],"assets/images/resized/0017/5338/175338v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://in.finance.yahoo.com/news/alivecor-raises-10-5m-series-120000432.html","source_description":"AliveCor Raises $10.5M in Series B Financing","raised_amount":10500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":10,"company":{"name":"AliveCor","permalink":"alivecor","image":{"available_sizes":[[[150,35],"assets/images/resized/0014/9115/149115v1-max-150x150.png"],[[250,59],"assets/images/resized/0014/9115/149115v1-max-250x250.png"],[[275,65],"assets/images/resized/0014/9115/149115v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/11/mabvax-therapeutics-closes-5-25m-series-financing.html","source_description":"MabVax Therapeutics Closes $5.25M in Series B Financing","raised_amount":5250000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":20,"company":{"name":"MabVax Therapeutics","permalink":"mabvax-therapeutics","image":{"available_sizes":[[[150,41],"assets/images/resized/0022/1358/221358v2-max-150x150.jpg"],[[250,69],"assets/images/resized/0022/1358/221358v2-max-250x250.jpg"],[[289,80],"assets/images/resized/0022/1358/221358v2-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Burrill Capital Fund IV","funded_year":2012,"funded_month":8,"funded_day":2,"raised_amount":505000000,"raised_currency_code":"USD","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120802e882p0i2n&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120802e882p0i2n%26from%3dalert%26pid%3d32","source_description":" Burrill & Co. Closes Fourth Life Sciences Fund at $505M "},{"name":"Burrill Brazil Fund I","funded_year":2012,"funded_month":1,"funded_day":13,"raised_amount":125000000,"raised_currency_code":"USD","source_url":"http://www.finsmes.com/2012/01/burrill-holds-close-brazil-fund-125m.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Burrill & Co. Holds First Close of Brazil Fund at $125M"}],"video_embeds":[],"external_links":[]}